TRT vs enclomiphene: which fits your goals and fertility plans?

TRT vs enclomiphene on testosterone, fertility, muscle, safety, FDA status and 2026 US cash prices, and what each means if you want children.

Published 2026-10-13By Anton Billstein

Contents

Does enclomiphene work as good as TRT?

Enclomiphene and TRT both raise testosterone levels, and their efficacy within the normal range was similar in a small trial, but they get there by different routes. Testosterone replacement therapy (TRT) supplies the hormone from outside, as a gel, injection or capsule. Enclomiphene does not add hormone: the drug blocks estrogen receptors in the hypothalamus, a control region of the brain. The signal that normally slows the pituitary gland drops away; the pituitary then releases more LH and FSH, two messengers that prompt the testes to produce their own testosterone and sperm. This control system is called the hypothalamic-pituitary-gonadal axis, or HPG axis. Enclomiphene belongs to the class of selective estrogen receptor modulators (SERMs) and is the pure trans-isomer of clomiphene^[1].

When treatment is warranted at all, the guidelines draw a narrow line. The American Urological Association (AUA) names a total testosterone level below 300 ng/dL as a reasonable threshold to support the diagnosis, measured on two separate mornings and combined with matching symptoms or signs^[2]. The Endocrine Society's 2018 guideline recommends making the diagnosis only in men with symptoms and unequivocally and consistently low testosterone values, and advises against routine screening of healthy men^[3].

How well enclomiphene lifts levels is shown by a small randomized phase II study published in BJU International in 2013, in men with secondary hypogonadism, meaning a disruption of the control by hypothalamus or pituitary rather than the testes themselves. After six weeks, the mean total testosterone in the highest-dose enclomiphene group (25 mg daily) was 604 ng/dL, versus 500 ng/dL under a testosterone gel; the difference between the groups was not statistically significant^[4].

TRT delivers testosterone from outside and dampens LH and FSH, because the brain registers the high level as surplus^[4].
Enclomiphene stimulates the body's own production; in the study, LH and FSH rose even above the normal range^[4].
Enclomiphene requires intact signalling: in primary hypogonadism, damage to the testes themselves, exogenous testosterone is the only option^[1].
Both routes require a diagnosis by a licensed clinician; neither drug is meant for self-treatment.

So whether enclomiphene works just as well depends on the goal. For men with a functioning HPG axis, it reached levels similar to a gel in this study. The data come from small studies with a few dozen participants over short periods; how stable the levels remain over years is less well studied than for TRT, which has been established for decades^[1].

Is enclomiphene safer than TRT?

There is no one-word answer, because the two approaches carry different risks. TRT has the broadest evidence base: known downsides include erythrocytosis, a rise in red blood cells, elevated estrogen levels, altered blood lipids and suppression of sperm production^[1]. The AUA recommends measuring hemoglobin and hematocrit before starting therapy and counselling patients about the increased polycythemia risk; whether testosterone therapy raises or lowers the risk of heart attack or stroke remains unresolved to this day^[2].

Enclomiphene does not dampen gonadal function; it stimulates it. In a retrospective comparison of 66 men published in Translational Andrology and Urology in 2024, adverse effects were significantly less frequent under enclomiphene than under clomiphene, with complaints such as decreased libido and reduced energy significantly rarer^[5]. A 2016 review in Expert Opinion on Pharmacotherapy attributes the estrogenic side effects reported with clomiphene to its other isomer, zuclomiphene, which is absent from pure enclomiphene^[1].

The decisive difference is regulatory approval: there is still no FDA-approved enclomiphene product. An application under the name Androxal received a Complete Response Letter from the FDA in 2015, according to HealthRX's enclomiphene report, a return of the application with conditions. Since then, the drug has been prepared by compounding pharmacies, which make medications individually, and insurers usually do not cover the cost^[6]. In June 2022, the FDA's Pharmacy Compounding Advisory Committee voted against including enclomiphene citrate on the list of bulk substances permitted for pharmacy compounding^[7]. For testosterone, the AUA conversely recommends prescribing commercially manufactured rather than compounded preparations where possible^[2].

Aspect	TRT	Enclomiphene
Approval (US)	FDA-approved products exist, but the FDA has restricted the approved indications: idiopathic, including age-related, hypogonadism is no longer an approved indication^[1]	No FDA-approved product; prepared by compounding pharmacies
Sperm production	Suppressed; azoospermia in 65% within 4 months in one evidence review^[8]	Maintained or increased in studies^[9]
Red blood cells	Increased risk; hemoglobin and hematocrit checks before starting recommended^[2]	No significant hematocrit change in a 66-man comparison^[5]
Commonly reported complaints	Elevated estrogen levels, altered blood lipids^[1]	Adverse effects significantly less frequent than under clomiphene in a 66-man comparison, including decreased libido and reduced energy^[5]

So enclomiphene sidesteps two well-documented TRT risks, suppression of sperm production and changes in blood counts. In return, it lacks approval, standardized quality controls and large long-term studies. Which trade-off fits you is a question for your blood values and a clinician.

Does enclomiphene build muscle like TRT?

TRT has the better evidence for muscle: the AUA states that testosterone therapy may improve lean body mass, as well as erectile function, libido, anemia, bone density and depressive symptoms, while the evidence for energy, fatigue, blood lipids or overall quality of life is rated as inconclusive^[2]. Because TRT keeps levels continuously in the target range, it acts on these goals directly and predictably.

Enclomiphene can support muscle gain only through the body's own production, and that has a physiological ceiling: levels rise only as high as the testes can maximally produce, not beyond. In the six-week study, enclomiphene 25 mg reached a mean of 604 ng/dL and a gel 500 ng/dL, both near the range the AUA describes as the treatment target, the middle third of the reference range, for many labs roughly 450 to 600 ng/dL^[4]^[2]. Levels far above the normal range, as steroid users pursue them, are not achievable with enclomiphene.

For real muscle gain, more than one hormone matters:

Progressive resistance training provides the strongest stimulus for muscle growth.
Adequate protein and total energy in the diet.
Sleep and recovery, because muscle is built mainly during rest phases.
Patience: measurable changes in body composition take months, not weeks.
The enclomiphene studies measure hormone levels and sperm parameters, not strength gains or muscle cross-section.

Realistic expectations help here. With a documented deficiency, both can help restore normal levels. Neither is a way to push testosterone or performance beyond normal limits, and there is no solid evidence for such promises.

Does enclomiphene mess up fertility?

Enclomiphene does not mess up fertility in the studies so far, and this is where the two options differ most clearly. Enclomiphene raises FSH and LH. FSH stimulates the Sertoli cells, which carry sperm production; LH keeps testosterone production in the Leydig cells going. In randomized studies with a testosterone gel as the comparison, sperm counts under enclomiphene were maintained or increased, while they fell under the gel^[4]. A retrospective analysis of 46 men, published in Cureus in 2023, showed a significant increase in total motile sperm after at least three months, from a median of 0.73 to 4.01 million^[9].

TRT works in the opposite direction. Testosterone supplied from outside suppresses FSH and LH so strongly that sperm production can come to a standstill: a 2018 review in The World Journal of Men's Health reports that testosterone used as a contraceptive led to azoospermia, the absence of sperm in the ejaculate, in 65 percent of men with normal sperm counts within four months^[8]. The Endocrine Society's 2018 guideline therefore recommends against testosterone therapy in men planning fertility in the near term^[10], and the AUA makes a strong recommendation not to prescribe exogenous testosterone to men who are currently trying to conceive^[2].

If you want children, this order makes sense:

Clarify the wish for children before therapy begins.
Reproductive work-up before starting therapy; the AUA recommends it for men with testosterone deficiency who want children^[2].
A semen analysis as a baseline, so changes remain measurable.
Check together with the clinician whether a SERM such as enclomiphene fits your situation.

Two caveats. The enclomiphene studies are small and short. And a normal sperm count in the ejaculate is no guarantee of pregnancy; fertility depends on many factors, including the partner's.

Is enclomiphene as strong as TRT?

Enclomiphene is as strong as TRT within the normal range, but not beyond it. Exogenous testosterone can in principle be dosed upward; the dose determines the level. Enclomiphene works through the body's own production and hits a natural ceiling, the maximum production capacity of the testes^[1]. For the guideline target range, that was enough in studies; for levels beyond it, it is not.

Costs differ too. Without insurance, HealthRX's enclomiphene cost report (updated May 2026) puts compounded enclomiphene at roughly 30 to 120 USD per month, depending on dose, pharmacy and whether a telehealth subscription is bundled, and telehealth bundles of consultation plus medication at about 99 to 199 USD per month^[6]. For comparison, TRT.tips' 2025 estimates put a budget protocol of compounded, self-administered testosterone injections at roughly 800 to 1,500 USD per year including labs and follow-up, and mid-range telehealth memberships at 1,500 to 2,500 USD per year^[11]. All figures refer to the US market and change frequently; other countries have different prices and supply routes.

Question	TRT	Enclomiphene
Ceiling of the level	Determined by the dose	Limited by the production capacity of the testes^[1]
Mean level after 6 weeks (study)	500 ng/dL under a gel^[4]	604 ng/dL under 25 mg daily^[4]
Cost frame (US, cash pay)	Roughly 800 to 2,500 USD per year including labs and follow-up^[11]	30 to 120 USD per month; telehealth packages 99 to 199 USD^[6]

So there is no general answer to which is stronger. Within the physiological target range, enclomiphene reached values comparable to a gel in the study cited. If you aim for higher levels, you need exogenous testosterone, but exactly those levels make side effects and fertility risks more likely.

Does enclomiphene preserve fertility on TRT?

Enclomiphene alongside TRT may preserve some fertility, but the evidence is weak. Some clinicians run enclomiphene in parallel to TRT to soften the negative feedback on the HPG axis and keep a degree of the body's own gonadal function. The AUA allows this approach as a conditional recommendation: in men with testosterone deficiency who wish to maintain fertility, aromatase inhibitors, hCG, selective estrogen receptor modulators or combinations of these may be used. hCG is a hormone preparation that stimulates testosterone production in the testes in men^[2].

This is an off-label use, meaning a use outside an approved indication. Randomized studies are lacking for the combination of TRT and enclomiphene; the evidence on SERM approaches rests mainly on small, retrospective and uncontrolled investigations^[1]. Close monitoring is therefore part of the concept: hormone levels, blood counts and semen analyses at regular intervals, adjusted to the course.

There is also a practical cost. If hCG is added to TRT to maintain testicular function, HealthRX puts the extra cost at roughly 80 to 200 USD per month^[6]. And if you stop testosterone entirely, recovery takes time: according to the 2018 review in The World Journal of Men's Health, hormonally induced azoospermia reversed in 64 to 84 percent of men, at a median of around 110 days, in some only after up to two years; in a study by Kohn and colleagues cited in that review, 30 percent of 66 men still had not reached a total motile sperm count above 5 million after twelve months^[8].

There are no large randomized studies on the combination of TRT plus enclomiphene.
Dose and duration are not standardized.
Whether the combination preserves sperm production long term is not proven.
More clinical experience exists for hCG than for clomiphene, but there are no data on comparative benefit^[12].

If fertility is a concern, the simplest path is not to risk the suppression in the first place, which is why the AUA recommendation above exists^[2]. Combination therapy is a tool for special situations and belongs in closely supervised hands.

Is TRT safer than steroids?

TRT is safer than anabolic steroid misuse because it is a prescribed, monitored treatment aimed at normal levels, while steroid misuse uses doses far above that range. Medical testosterone therapy treats a documented deficiency: it targets levels in the physiological range and is prescribed and monitored by a licensed clinician, for example with testosterone measurements every six to twelve months^[2]. Anabolic-androgenic steroids (AAS), by contrast, are usually taken at doses far above the normal range, often without a medical indication and without monitoring. A 2019 review in The Journal of Clinical Endocrinology and Metabolism draws the distinction this way: replacement is meant to return a person to a normal state, while use beyond the baseline is pharmacotherapy judged by different standards^[12].

The risks of steroid misuse are well documented. AAS demonstrably suppress the body's own sex hormone production, markedly lower HDL cholesterol and impair fertility; oral alkylated steroids can damage the liver. Men who use high doses for more than a year can retain hypogonadism symptoms and low testosterone values for years even after stopping. The same 2019 review estimates the lifetime prevalence of AAS use worldwide at 1 to 5 percent^[12].

The main differences:

Medical TRT: prescribed by a licensed clinician, dose in the physiological target range, defined monitoring.
Steroid misuse: doses far above the physiological range, usually without an indication and without blood count or hormone monitoring.
Fertility: TRT suppresses sperm production, usually reversibly; high-dose steroid use can permanently weaken testicular function^[12].
Anyone who suspects symptoms of testosterone deficiency needs measurements and diagnostics, not a self-experiment.

A properly supervised TRT and steroid misuse are therefore not the same, and neither is the same as enclomiphene. Which path fits your goals and family plans is decided by your blood values, medical history and desire for children, not by headlines. Take the decision points from this article to a licensed clinician or pharmacist and have your values assessed in context. Related Elenra guides cover TRT costs and options, enclomiphene in practice and testosterone testing, and our guide to study types explains evidence quality in plain language, without diagnosing.

Frequently asked questions

What is the difference between clomiphene and enclomiphene?

Clomiphene is a mixture of two isomers, zuclomiphene and enclomiphene. Enclomiphene is the isolated isomer; in a 66-patient comparison from 2024 it raised estradiol less and caused fewer reported side effects than clomiphene.

Does insurance cover the cost of enclomiphene?

Usually not. No enclomiphene product is FDA-approved and it is prepared by compounding pharmacies, so commercial insurance rarely covers it. Cash prices run about 30 to 120 USD per month (HealthRX, May 2026).

How quickly does enclomiphene affect testosterone levels?

Within weeks in the trials. In a small phase II study, mean total testosterone in the 25 mg enclomiphene group reached 604 ng/dL after six weeks in men with secondary hypogonadism.

Can I use TRT if I want children in the near future?

Usually not. The Endocrine Society's 2018 guideline recommends against testosterone therapy in men planning fertility in the near term, and the AUA advises against it for men currently trying to conceive, because exogenous testosterone suppresses LH and FSH and with them sperm production.

Are anabolic steroids the same as TRT?

No. Medical TRT aims to bring testosterone levels back into a normal physiological range. Anabolic steroids, by contrast, are usually misused at extremely high doses, which can lead to serious health damage.